ASP Isotopes (ASPI) Common Equity (2021 - 2026)

ASP Isotopes' Common Equity history runs 6 years deep, the most recent figure standing at $299.0 million for Q1 2026.

• In Q1 2026, Common Equity rose 553.89% year-over-year to $299.0 million; the TTM figure through Mar 2026 stood at $299.0 million (up 553.89% YoY), while the FY2025 annual figure was $262.9 million, up 413.8% from the prior year.
• Common Equity was $299.0 million for Q1 2026 at ASP Isotopes, up from $262.9 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $299.0 million in Q1 2026 to a low of $6.3 million in Q3 2022.
• Historically, Common Equity has averaged $54.9 million across 5 years, with a median of $14.4 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Common Equity advanced 9.36% in 2024, then jumped 553.89% in 2026.
• A 5-year view of Common Equity shows it stood at $9.8 million in 2022, then surged by 91.81% to $18.8 million in 2023, then jumped by 171.72% to $51.2 million in 2024, then jumped by 413.8% to $262.9 million in 2025, then gained by 13.74% to $299.0 million in 2026.
• The last three Common Equity figures came in at $299.0 million (Q1 2026), $262.9 million (Q4 2025), and $96.6 million (Q3 2025), per Business Quant data.